Loading…

A novel spleen‐dedicated stiffness measurement by FibroScan® improves the screening of high‐risk oesophageal varices

Background & Aims Several non‐invasive tests (NITs) have been developed to diagnose oesophageal varices (EV), including the recent Baveno VI criteria to rule out high‐risk varices (HRV). Spleen stiffness measurement (SSM) with the standard FibroScan® (SSM@50Hz) has been evaluated. However, the E...

Full description

Saved in:
Bibliographic Details
Published in:Liver international 2020-01, Vol.40 (1), p.175-185
Main Authors: Stefanescu, Horia, Marasco, Giovanni, Calès, Paul, Fraquelli, Mirella, Rosselli, Matteo, Ganne‐Carriè, Nathalie, Ledinghen, Victor, Ravaioli, Federico, Colecchia, Antonio, Rusu, Corina, Andreone, Pietro, Mazzella, Giuseppe, Festi, Davide
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background & Aims Several non‐invasive tests (NITs) have been developed to diagnose oesophageal varices (EV), including the recent Baveno VI criteria to rule out high‐risk varices (HRV). Spleen stiffness measurement (SSM) with the standard FibroScan® (SSM@50Hz) has been evaluated. However, the EV grading could be underestimated because of a ceiling threshold (75 kPa) of the SSM@50Hz. The aims were to evaluate SSM by a novel spleen‐dedicated FibroScan® (SSM@100Hz) for EV diagnosis compared with SSM@50Hz, other validated NITs and Baveno VI criteria. Methods This prospective multicentre study consecutively enrolled patients with chronic liver disease; blood data, endoscopy, liver stiffness measurement (LSM), SSM@50Hz and SSM@100Hz were collected. Results Two hundred and sixty patients met inclusion criteria. SSM@100Hz success rate was significantly higher than that of SSM@50Hz (92.5% vs 76.0%, P 
ISSN:1478-3223
1478-3231
DOI:10.1111/liv.14228